EFX

Understanding EFX – Key Facts for Investors

Shares of Finance sector company Equifax moved 0.9% today, and are now trading at a price of $275.88. The Large-Cap stock's daily volume was 202,759 compared to its average volume of 1,034,896. The S&P 500 index returned a -0.0% performance.

Equifax Inc. operates as a data, analytics, and technology company. The company is based in Atlanta and has 15,000 full time employees. Its market capitalization is $34,195,257,344. Equifax currently offers its equity investors a dividend that yields 0.6% per year.

19 analysts are following Equifax and have set target prices ranging from $272.0 to $380.0 per share. On average, they have given the company a rating of buy. At today's prices, EFX is trading -11.95% away from its average analyst target price of $313.32 per share.

Over the last year, EFX's share price has increased by 11.0%, which represents a difference of -16.4% when compared to the S&P 500. The stock's 52 week high is $309.63 per share whereas its 52 week low is $213.02. With average free cash flows of $383.88 Million that have been growing at an average rate of 8.0% over the last 5 years, Equifax is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 1,116,800 601,300 515,500 288.76
2022 757,100 624,500 132,600 -84.68
2021 1,334,800 469,000 865,800 64.95
2020 946,200 421,300 524,900 711.77
2019 313,800 399,600 -85,800 -124.49
2018 672,200 321,900 350,300
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS